Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies

Detalles Bibliográficos
Autores principales: Deng, Zhenan, Jin, Meiling, Ou, Changxing, Jiang, Wei, Zhao, Jianping, Liu, Xiaoxia, Sun, Shenghua, Tang, Huaping, He, Bei, Cai, Shaoxi, Chen, Ping, Wu, Penghui, Liu, Yujing, Kang, Jian, Zhang, Yunhui, Huang, Mao, Xu, Jinfu, Huang, Kewu, Li, Qiang, Zhang, Xiangyan, Fu, Xiuhua, Wang, Changzheng, Shen, Huahao, Zhu, Lei, Shi, Guochao, Qiu, Zhongmin, Wen, Zhongguang, Wei, Xiaoyang, Gu, Wei, Wei, Chunhua, Wang, Guangfa, Xie, Lixin, Lin, Jiangtao, Tang, Yuling, Han, Zhihai, Chung, Kian Fan, Zhang, Qingling, Zhong, Nanshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106261/
https://www.ncbi.nlm.nih.gov/pubmed/36752798
http://dx.doi.org/10.1097/CM9.0000000000002556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106261/
https://www.ncbi.nlm.nih.gov/pubmed/36752798
http://dx.doi.org/10.1097/CM9.0000000000002556

Ejemplares similares